# Zemaira

NDC: 0053-7201
Generic name: alpha-1-proteinase inhibitor human
Labeler / Manufacturer: CSL Behring LLC
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20030708

FDA application: BLA125078

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0053-7201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0053-7201